Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy.
Magrini N, Formoso G, Marata AM, Capelli O, Maestri E, Voci C, Nonino F, Brunetti M, Paltrinieri B, Maltoni S, Magnano L, Bonacini MI, Daya L, Viani N. Magrini N, et al. Among authors: magnano l. BMC Health Serv Res. 2007 Sep 28;7:158. doi: 10.1186/1472-6963-7-158. BMC Health Serv Res. 2007. PMID: 17903266 Free PMC article. Clinical Trial.
Long term effectiveness on prescribing of two multifaceted educational interventions: results of two large scale randomized cluster trials.
Magrini N, Formoso G, Capelli O, Maestri E, Nonino F, Paltrinieri B, Del Giovane C, Voci C, Magnano L, Daya L, Marata AM; INDRA-NET study group. Magrini N, et al. Among authors: magnano l. PLoS One. 2014 Oct 17;9(10):e109915. doi: 10.1371/journal.pone.0109915. eCollection 2014. PLoS One. 2014. PMID: 25329386 Free PMC article. Clinical Trial.
Say Dr No to shifting from falls to osteoporosis.
Maestri E, Capelli O, Formoso G, Magnano L, Marata AM, Magrini N. Maestri E, et al. Among authors: magnano l. BMJ. 2008 Nov 25;337:a2684. doi: 10.1136/bmj.a2684. BMJ. 2008. PMID: 19033339 No abstract available.
Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047].
Kim TM, Taszner M, Novelli S, Cho SG, Villasboas JC, Merli M, Jiménez-Ubieto A, Tessoulin B, Poon LM, Tucker D, Walewski J, Yi S, Song Y, Chong G, Bachy E, Guidez S, Alonso A, Jagadeesh D, Zhang W, Magnano L, Iskierka-Jażdżwska E, Tani M, Shen B, Uppala A, Zhu M, Shariff S, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Luminari S; ELM-2 Investigators. Kim TM, et al. Among authors: magnano l. Ann Oncol. 2024 Dec 2:S0923-7534(24)04945-7. doi: 10.1016/j.annonc.2024.11.009. Online ahead of print. Ann Oncol. 2024. PMID: 39627085 Free article. No abstract available.
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases.
Sangiorgio V, Palasciano A, Tabanelli V, Giné E, Guerra L, Pagni F, Casiraghi A, Casaroli I, Frigola G, Magnano L, Gambacorti-Passerini C, Derenzini E, Vanazzi A, Campo E. Sangiorgio V, et al. Among authors: magnano l. Hum Pathol. 2024 Oct;152:105651. doi: 10.1016/j.humpath.2024.105651. Epub 2024 Aug 28. Hum Pathol. 2024. PMID: 39214241 No abstract available.
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma.
Kim TM, Taszner M, Novelli S, Cho SG, Villasboas JC, Merli M, Jiménez-Ubieto A, Tessoulin B, Poon LM, Tucker D, Walewski J, Yi S, Song Y, Chong G, Bachy E, Guidez S, Alonso A, Jagadeesh D, Zhang W, Magnano L, Iskierka-Jażdżewska E, Tani M, Shen B, Uppala A, Zhu M, Shariff S, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Luminari S; ELM-2 Investigators. Kim TM, et al. Among authors: magnano l. Ann Oncol. 2024 Nov;35(11):1039-1047. doi: 10.1016/j.annonc.2024.08.2239. Epub 2024 Aug 13. Ann Oncol. 2024. PMID: 39147364 Free article. Clinical Trial.
Efficacy of escalating therapy with brentuximab vedotin-AVD in advanced stage Hodgkin lymphoma patients with positive interim positron emission tomography after ABVD.
Martínez C, Carcelero E, Gutiérrez A, Sancho E, Martí-Tutusaus JM, Magnano L, Mozas P, Fernández-Avilés F, Antelo MG, Setoain X, Rodríguez S, Esteve J. Martínez C, et al. Among authors: magnano l. Hematol Oncol. 2024 Sep;42(5):e3299. doi: 10.1002/hon.3299. Hematol Oncol. 2024. PMID: 39132926
Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes.
Gras E, Aiello TF, Chumbita M, Gallardo-Pizarro A, Monzó-Gallo P, Teijón-Lumbreras C, Suárez-Lledó M, Magnano L, Tuset M, Marcos MÁ, Soriano A, Garcia-Vidal C. Gras E, et al. Among authors: magnano l. J Antimicrob Chemother. 2024 Sep 3;79(9):2364-2368. doi: 10.1093/jac/dkae237. J Antimicrob Chemother. 2024. PMID: 38985649
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
Dobaño-López C, Valero JG, Araujo-Ayala F, Nadeu F, Gava F, Faria C, Norlund M, Morin R, Bernes-Lasserre P, Arenas F, Grau M, López C, López-Oreja I, Serrat N, Martínez-Farran A, Hernández L, Playa-Albinyana H, Giménez R, Beà S, Campo E, Lagarde JM, López-Guillermo A, Magnano L, Colomer D, Bezombes C, Pérez-Galán P. Dobaño-López C, et al. Among authors: magnano l. Blood Cancer J. 2024 May 2;14(1):75. doi: 10.1038/s41408-024-01041-7. Blood Cancer J. 2024. PMID: 38697976 Free PMC article.
Real-Life Comparison of Antivirals for SARS-CoV-2 Omicron Infection in Patients With Hematologic Malignancies.
Aiello TF, Peyrony O, Chumbita M, Monzó P, Lopera C, Puerta-Alcalde P, Magnano L, Fernández-Avilés F, Cuesta G, Tuset M, Mensa J, Esteve J, Marcos MA, Soriano A, Garcia-Vidal C. Aiello TF, et al. Among authors: magnano l. Influenza Other Respir Viruses. 2024;18(3):e13264. doi: 10.1111/irv.13264. Influenza Other Respir Viruses. 2024. PMID: 38468434 Free PMC article.
95 results